Platform
Features
0 followers
Ashvattha Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel hydroxyl dendrimer (HD) therapeutics (HDTs) to treat unmet medical needs in oncology, ophthalmology, and inflammatory diseases.
Industries
Headquarters
Employees
Links
Jeffrey L. Cleland
6 members
2 members
Vaxcyte
2 followers
Aura Biosciences
1 follower
Apogee Therapeutics
Landmark Bio
Cellares
Kula Bio
Thermo Fisher Scientific
148 followers
Genentech
144 followers
Gilead Sciences
121 followers
Regeneron
89 followers
Illumina
67 followers
Discover companies